Susquehanna International Group’s 60 Degrees Pharmaceuticals Warrant SXTPW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$910 Buy
18,163
+1,109
+7% +$71 ﹤0.01% 13033
2025
Q4
$1.07K Sell
17,054
-286
-2% -$14 ﹤0.01% 12148
2025
Q3
$642 Buy
+17,340
New +$1.19K ﹤0.01% 12214
2025
Q2
Sell
-15,140
Closed -$348 13690
2025
Q1
$348 Buy
+15,140
New +$418 ﹤0.01% 12350

Other funds holding SXTPW

Susquehanna International Group's SXTPW Position: Q1 2026 in Review

Susquehanna International Group increased its 60 Degrees Pharmaceuticals Warrant (SXTPW) stake by 6.5% in Q1 2026, buying an estimated $71 and bringing the position to 18,163 shares worth $910. The position accounts for ﹤0.01% of the portfolio, ranked #13033.

Susquehanna International Group first reported a position in SXTPW in Q1 2025 and has held it in 4 quarters since. The position peaked at $1.07K in Q4 2025. 8 funds tracked by Wall St. Rank hold SXTPW as of Q1 2026.

  • Susquehanna International Group held 18,163 shares of 60 Degrees Pharmaceuticals Warrant worth $910 as of Q1 2026.
  • Susquehanna International Group bought 1,109 60 Degrees Pharmaceuticals Warrant shares in Q1 2026, an estimated $71.
  • 60 Degrees Pharmaceuticals Warrant made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #13033 holding.
  • Susquehanna International Group first reported a position in 60 Degrees Pharmaceuticals Warrant in Q1 2025 and has held it in 4 quarters since.
  • Susquehanna International Group's 60 Degrees Pharmaceuticals Warrant position peaked at $1.07K in Q4 2025.
  • 8 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals Warrant as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.